Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients

: Silvennoinen R, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Saily M, Sikio A, Opas J, Penttila K, Kuittinen T, Honkanen T, Lundan T, Juvonen V, Luukkaala T, Remes K

Publisher: WILEY-BLACKWELL

: 2013

: British Journal of Haematology

: BRITISH JOURNAL OF HAEMATOLOGY

: BRIT J HAEMATOL

: 4

: 160

: 4

: 561

: 564

: 4

: 0007-1048

DOI: https://doi.org/10.1111/bjh.12139